Good Pharma Scorecard

We rank bio-pharmaceutical companies and new drugs on ethics and public health performance criteria, focusing on issues that are critical to patients.

The Good Pharma Scorecard ranks companies and new medicines on their clinical trial transparency and data-sharing performance, taking into account ethics and legal standards. Subsequent versions of the scorecard will also evaluate the integrity of clinical trial designs, the accessibility of medicines, drug marketing practices, and other ethics and human rights issues.

Clinical Trial Transparency and Data Sharing
Are Important Because:

Transparency is key to protecting and respecting research participants and  users of medicines and vaccines

Evidenced based medicine requires all evidence to be in the public domain

Being able to learn from what other scientists have already done- both accomplishments and failures- stimulates innovation and ultimately the delivery of lifesaving results.

Transparency is key to maximizing the value of generated trial data and people’s participation in trials

Opacity can drive up costs of research and care

Transparency and data-sharing enable validation and replication of study findings

Rankings

View Good Pharma Scorecard rankings by

Drug
Sponsor/Co-Sponsor
Indication
Drug
Sponsor/
Co-Sponsor
Indication
Transparency
Score
# 1 Alecensa Roche Lymphoma & Lung Cancer
Roche
Lymphoma & Lung Cancer
# 1 Bridion Merck Neuromuscular Blockade
Merck
Neuromuscular Blockade
# 1 Cotellic Roche / Genentech Melanoma
Roche / Genentech
Melanoma
# 1 Entresto Novartis Heart Failure
Novartis
Heart Failure
# 1 Ibrance Pfizer Breast Cancer
Pfizer
Breast Cancer
# 1 Odomzo Novartis Basal Cell Carcinoma
Novartis
Basal Cell Carcinoma
# 1 Tagrisso AstraZeneca Lung Cancer
AstraZeneca
Lung Cancer
# 1 Tresiba/ Ryzodeg Novo Nordisk Diabetes Mellitus
Novo Nordisk
Diabetes Mellitus
# 9 Daklinza Bristol-Myers Squibb Hepatitis C
Bristol-Myers Squibb
Hepatitis C
# 10 Farydak Novartis Multiple Myeloma
Novartis
Multiple Myeloma
95% Median Median score

Median: 95%

# 11 Genvoya Gilead HIV
Gilead
HIV
# 12 Yondelis Johnson & Johnson / Janssen Liposarcoma & Leiomyosarcoma
Johnson & Johnson / Janssen
Liposarcoma & Leiomyosarcoma
# 13 Zurampic AstraZeneca Hyperuricemia with Gout
AstraZeneca
Hyperuricemia with Gout
# 14 Addyi Valeant Hypoactive Sexual Desire Disorder
Valeant
Hypoactive Sexual Desire Disorder
# 15 Kybella Allergan Double Chin
Allergan
Double Chin
# 16 Corlanor Amgen Heart Failure
Amgen
Heart Failure
# 17 Vraylar Allergan Schizophrenia / Bipolar Disorder
Allergan
Schizophrenia / Bipolar Disorder
# 18 Viberzi Allergan IBS
Allergan
IBS
# 19 Avycaz Allergan Intra-abdominal & UTI Infections
Allergan
Intra-abdominal & UTI Infections